Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
6.07
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-21.47 Insider Own16.81% Shs Outstand3.74M Perf Week-6.62%
Market Cap22.70M Forward P/E- EPS next Y-1.53 Insider Trans2.73% Shs Float3.11M Perf Month-16.51%
Income-13.29M PEG- EPS next Q-0.76 Inst Own24.80% Short Float3.77% Perf Quarter66.30%
Sales0.57M P/S39.83 EPS this Y34.26% Inst Trans-47.24% Short Ratio3.15 Perf Half Y46.27%
Book/sh5.43 P/B1.12 EPS next Y41.21% ROA-44.74% Short Interest0.12M Perf Year27.78%
Cash/sh6.78 P/C0.90 EPS next 5Y- ROE-55.10% 52W Range2.78 - 8.85 Perf YTD29.15%
Dividend Est.- P/FCF- EPS past 5Y-147.45% ROI-61.51% 52W High-31.39% Beta1.02
Dividend TTM- Quick Ratio6.15 Sales past 5Y0.00% Gross Margin- 52W Low118.35% ATR (14)0.61
Dividend Ex-Date- Current Ratio6.15 EPS Y/Y TTM79.25% Oper. Margin-2538.61% RSI (14)45.41 Volatility5.94% 10.30%
Employees9 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin-2334.27% Recom1.00 Target Price15.67
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q63.06% Payout- Rel Volume0.00 Prev Close6.07
Sales Surprise-91.45% EPS Surprise-19.99% Sales Q/Q- EarningsMar 26 BMO Avg Volume37.19K Price6.07
SMA20-10.88% SMA50-4.43% SMA20034.23% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Dec-28-20Downgrade Robert W. Baird Outperform → Neutral
Dec-16-20Initiated Berenberg Buy $37
Sep-29-20Resumed JP Morgan Neutral $25
Jun-22-20Initiated H.C. Wainwright Neutral $30
Apr-21-20Initiated Robert W. Baird Outperform $45
Oct-28-19Initiated RBC Capital Mkts Outperform $33
Oct-28-19Initiated Morgan Stanley Equal-Weight $23
Oct-28-19Initiated JP Morgan Neutral $23
Mar-26-24 01:53PM
07:45AM
Mar-11-24 08:30AM
08:29AM
Mar-05-24 04:45PM
08:01AM Loading…
Feb-06-24 08:01AM
Jan-30-24 08:00AM
Jan-04-24 04:05PM
Nov-09-23 04:05PM
Oct-24-23 08:00AM
Oct-16-23 08:30AM
Sep-19-23 08:00AM
Sep-11-23 08:00AM
Sep-06-23 04:05PM
Aug-24-23 07:30AM
07:30AM Loading…
Aug-10-23 07:30AM
Jun-14-23 08:00AM
May-30-23 08:30AM
May-15-23 04:05PM
May-08-23 08:00AM
Apr-24-23 09:55AM
Apr-04-23 12:00PM
Mar-30-23 04:05PM
Mar-16-23 08:00AM
Mar-07-23 08:00AM
Mar-01-23 04:05PM
Feb-27-23 04:05PM
Feb-22-23 08:41PM
04:05PM
Feb-15-23 08:00AM
07:00AM Loading…
Feb-13-23 07:00AM
Jan-30-23 08:00AM
Jan-19-23 08:00AM
Jan-12-23 09:56AM
Jan-11-23 08:00AM
Nov-09-22 04:15PM
Sep-22-22 06:00PM
Sep-08-22 08:00AM
Aug-11-22 04:15PM
Aug-02-22 08:00AM
May-19-22 06:30AM
May-16-22 09:21AM
Mar-15-22 04:15PM
Mar-02-22 04:41AM
Jan-14-22 10:00AM
Jan-06-22 08:00AM
Dec-14-21 08:00AM
Dec-13-21 08:00AM
Dec-10-21 10:30AM
Dec-09-21 12:30PM
08:00AM
Nov-08-21 04:15PM
Nov-04-21 04:15PM
Sep-21-21 08:39AM
07:01AM
Sep-20-21 04:15PM
08:42AM
Sep-14-21 08:00AM
Sep-03-21 07:21AM
Aug-12-21 04:15PM
06:00AM
Aug-05-21 05:00PM
Jul-21-21 08:00AM
Jun-18-21 08:34AM
Jun-17-21 09:19AM
Jun-16-21 09:24AM
08:00AM
Jun-13-21 12:45PM
Jun-04-21 01:47AM
May-21-21 06:00AM
May-18-21 06:00AM
May-06-21 04:15PM
Apr-16-21 09:15AM
Apr-08-21 11:15AM
Mar-16-21 04:15PM
Feb-16-21 08:04AM
Jan-22-21 12:00PM
Jan-08-21 08:00AM
Dec-30-20 11:40AM
Dec-29-20 07:24PM
10:32AM
Dec-28-20 04:57PM
02:22PM
08:00AM
Dec-10-20 10:33PM
Nov-30-20 08:00AM
Nov-23-20 10:00AM
Nov-19-20 08:00AM
Nov-05-20 04:15PM
Oct-30-20 04:00AM
Oct-14-20 08:00AM
Oct-07-20 08:00AM
Sep-29-20 08:00AM
06:28AM
Sep-18-20 08:00AM
Sep-03-20 08:00AM
Aug-11-20 04:15PM
Jul-16-20 07:00AM
Jul-01-20 10:32AM
07:12AM
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seizinger Bernd R.DirectorMar 13 '24Buy7.296,86050,00933,685Mar 14 08:53 PM
HENNEMAN JOHN B IIIDirectorMar 13 '24Buy7.296,86050,0098,139Mar 14 08:52 PM
Gilad OrenPresident, CEOMar 13 '24Buy7.292,00014,580324,770Mar 14 08:51 PM
Hamill John P.SrVP/CFO/Prin Fin & Acct OfcrMar 13 '24Buy7.291,0107,36315,503Mar 14 08:54 PM
Seizinger Bernd R.DirectorJun 07 '23Buy3.686,02922,19226,325Jun 08 04:34 PM
Seizinger Bernd R.DirectorJun 06 '23Buy3.634,06814,76420,296Jun 08 04:34 PM